Intelligent Precision Knee Preservation System for Knee Osteoarthritis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-70
SponsorFirst Affiliated Hospital of Wenzhou Medical University

About this trial

The goal of this clinical trial is to verify whether the "dynamic dual-mode alignment optimization + intelligent precision knee-preserving system" (integrating static/kinematic target alignment, CT-based preoperative three-dimensional \[3D\] planning, 3D-printed guide plates, and intraoperative augmented reality \[AR\] real-time feedback) achieves a greater relative reduction in peak knee adduction moment (KAM) at 12 months postoperatively, while maintaining or improving knee clinical function and without increasing perioperative or long-term complication rates, compared with traditional knee-preserving strategies. The target population is patients aged 40-70 years with knee osteoarthritis (KOA; Kellgren-Lawrence grade II-III) who require high tibial osteotomy (HTO) for unilateral medial-compartment disease with mild-to-moderate varus deformity and who meet the inclusion and exclusion criteria.

The main questions are:

* Can the dynamic dual-mode alignment + intelligent precision system achieve a greater relative reduction in peak KAM at 12 months postoperatively than traditional knee-preserving strategies? * Can this system improve static alignment accuracy, dynamic load parameters (e.g., KAM impulse and varus thrust), and patient-reported outcome (PRO) scores without increasing complication rates? * Can 3D-printed patient-specific instrumentation (PSI) guide plates and real-time AR feedback reduce intraoperative radiation exposure and shorten operative time compared with traditional methods?

Researchers will compare:

Kinematic alignment (KA), traditional mechanical alignment (MA), and dynamic dual-mode alignment (DA) to evaluate the relative performance of alignment strategies;

3D-printed PSI-guided HTO versus traditional fluoroscopy-guided HTO to assess the efficacy of PSI; and

AR-assisted intraoperative adjustment versus traditional fluoroscopy-based adjustment to evaluate the precision of AR navigation.

Participants will:

* Complete preoperative assessments, including laboratory tests (complete blood count, biochemistry, coagulation), imaging (full-length, weight-bearing lower-limb radiographs; knee CT and/or MRI as indicated), 3D gait analysis (to measure KAM, KAM impulse, and varus thrust), and PRO assessments (KOOS, WOMAC, and Lysholm scores) * Receive assigned surgical interventions: the DA group will undergo HTO guided by dual-mode alignment plus 3D-printed PSI and intraoperative AR feedback; the MA and KA groups will undergo HTO based on traditional or kinematic alignment, respectively; the traditional HTO group will undergo surgery relying on intraoperative fluoroscopy and surgeon experience. * Attend follow-up visits at 6 weeks, 3 months, 6 months, and 12 months postoperatively, including imaging to assess alignment accuracy and bone healing, gait analysis, PRO assessments, and complication monitoring. * Record medication use and rehabilitation compliance throughout the study period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 40 and 70 years;

Unilateral medial compartment knee osteoarthritis (mild to moderate pain);

Mild to moderate varus deformity (5°-15°);

Coronal MRI showing medial meniscus extrusion (MME) >3 mm and flexion contracture <10°;

Disqualifiers

Patients with concomitant inflammatory arthritis (e.g., rheumatoid arthritis) or systemic inflammatory diseases;

Patients with severe varus deformity (>10°) or flexion contracture >10°;

Patients with lateral meniscus pathology (tear, discoid meniscus) or knee joint instability;

Patients with a history of major knee trauma, infection, or prior knee surgery;

Trial design

Design model

Parallel

Treatments tested in this trial

  • HTO procedure

    Behavioral

    HTO procedure for knee osteoarthritis

Treatment groups

150 Participants
are divided into 3 treatment groups
Group A: MA groupPlacebo comparator 1 intervention
Group B: KA GroupExperimental treatment 1 intervention
Group C: DA groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Relative ΔKAM (%)

Relative ΔKAM (%) = \[(KAM\_follow-up - KAM\_preoperative) / KAM\_preoperative\] × 100%

Time frame
Preoperative, and 6 weeks, 3 months, 6 months, 12 months postoperatively
2

HKA Accuracy

HKA accuracy is defined as the proportion of operated knees whose hip-knee-ankle (HKA) angle falls within the prespecified target window (±2°) on full-length, weight-bearing radiographs at 12 months postoperatively.

Time frame
Preoperative, and 12 months postoperatively
3

KOOS score

Knee Injury and Osteoarthritis Outcome Score (KOOS) is a self-administered questionnaire (paper or electronic; 1-week recall) with 42 items across five subscales: Symptoms, Pain, Activities of Daily Living (ADL), Sport and Recreation Function (Sport/Rec), and Knee-related Quality of Life (QOL). Items are rated 0-4. For each subscale, raw scores are summed and transformed to a 0-100 scale using: Score = 100 - \[(sum of item scores × 100) ÷ (4 × number of items)\]. Minimum = 0 (worst outcome); Maximum = 100 (best outcome); higher scores indicate better status. Subscales are reported separately. If reported, "KOOS4" is the mean of Pain, Symptoms, Sport/Rec, and QOL, also on a 0-100 scale with 0 = worst and 100 = best (higher = better).

Time frame
Preoperative, and 6 weeks, 3 months, 6 months, 12 months postoperatively
4

WOMAC Osteoarthritis Index

The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index is a self-administered questionnaire designed to assess pain, stiffness, and physical function in patients with hip and knee osteoarthritis. It contains 24 items across three subscales: pain (5 items), stiffness (2 items), and physical function (17 items). Each item is scored on a Likert scale (0-4; none to extreme) or sometimes a 100-mm visual analogue scale, depending on the version used. Scores are summed for each subscale and can be normalized to a 0-100 scale (higher scores indicate worse symptoms).

Time frame
Preoperative, and 6 weeks, 3 months, 6 months, 12 months postoperatively

Secondary outcomes

1

MCID achievement rate

Minimal Clinically Important Difference (MCID) achievement rate : 1. For the target outcome, compute each participant's change from baseline to follow-up, signed so that improvement is positive (e.g., Δᵢ = Follow-up - Baseline for "higher=better"; Δᵢ = Baseline - Follow-up for "higher=worse"). 2. Mark a responder if Δᵢ ≥ MCID (or if using percent MCID: Δ%ᵢ = Δᵢ / Baseline × 100 ≥ MCID%). 3. MCID achievement rate (%) = (number of responders ÷ number analyzed at that time point) × 100.

Time frame
Preoperative, and 6 weeks, 3 months, 6 months, 12 months postoperatively
2

Operative time

Operative time is calculated as the interval from the first skin incision to completion of skin closure, recorded in minutes from the operating-room record.

Time frame
Intraoperative
3

Number of fluoroscopic shots

The total count of discrete single-image X-ray exposures acquired on the patient from first skin incision to completion of skin closure, as recorded by the C-arm exposure log/PACS.

Time frame
Intraoperative
4

Reoperation rate

The proportion of patients requiring reoperation within 12 months of follow-up due to mechanical failure, fracture, or implant-related issues

Time frame
12 months postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: